LexaGene (CVE:LXG) Stock Price Down 19.2% – Should You Sell?

LexaGene Holdings Inc. (CVE:LXG) shares fell 19.2% on Friday . The stock traded as low as C$0.10 and last traded at C$0.11. 2,135,377 shares traded hands during mid-day trading, an increase of 1,156% from the average session volume of 170,061 shares. The stock had previously closed at C$0.13.

LexaGene Stock Down 19.2 %

The firm has a market cap of C$14.77 million, a P/E ratio of -1.31 and a beta of 2.26. The firm’s 50-day moving average price is C$0.11 and its 200 day moving average price is C$0.11. The company has a debt-to-equity ratio of 138.01, a current ratio of 1.39 and a quick ratio of 1.13.

LexaGene Company Profile

LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.